{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:44:19Z","timestamp":1787168659574,"version":"build-2736575974"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.567210","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:11:23Z","timestamp":1603066283000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Olle","family":"Ringd\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3389\/fimmu.2019.01246","article-title":"Bone marrow transplantation 1957-2019","volume":"10","author":"Simpson","year":"2019","journal-title":"Front Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","article-title":"One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation","volume":"49","author":"Thomas","year":"1977","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1172\/JCI108680","article-title":"Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. prognostic factors associated with graft versus host disease and survival","volume":"59","author":"Storb","year":"1977","journal-title":"J Clin Invest."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/S0140-6736(95)92597-X","article-title":"Allogeneic bone marrow transplantation for lysosomal storage diseases. the European group for bone marrow transplantation","volume":"345","year":"1995","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","article-title":"Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial","volume":"73","author":"Storb","year":"1989","journal-title":"Blood."},{"key":"B6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00007890-198507000-00009","article-title":"Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy","volume":"40","author":"Ringden","year":"1985","journal-title":"Transplantation."},{"key":"B7","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/MPG.0000000000001776","article-title":"Choice of endoscopic procedure in children with clinically suspected gastrointestinal graft-versus-host disease","volume":"66","author":"M\u00e5rtensson","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e13867","DOI":"10.1111\/ctr.13867","article-title":"Clinical relevance of endoscopy with histopathological assessment in children with suspected gastrointestinal graft-versus-host disease","volume":"5","author":"M\u00e5rtensson","year":"2020","journal-title":"Clin Transplant."},{"key":"B9","first-page":"1","article-title":"Diagnostic disagreement between clinical standard histopathological-, and retrospective assessment of histopathology-based gastrointestinal graft-versus-host disease in children","author":"M\u00e5rtensson","year":"2020","journal-title":"Pediatr Transpl."},{"key":"B10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-0609.1979.tb00428.x","article-title":"Successful treatment with prednisone and graft-versus-host disease in an allogeneic bone marrow transplant recipient","volume":"22","author":"Groth","year":"1979","journal-title":"Scand J Haematol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.bbmt.2012.04.006","article-title":"Secondary treatment of acute graft-versus-host disease: a critical review","volume":"18","author":"Martin","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"key":"B12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic of bone marrow. analysis of precursor cells for osteogenic and hematopoietic tissues","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringden","year":"2006","journal-title":"Transplantation."},{"key":"B15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/8756-3282(92)90363-2","article-title":"Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies","volume":"13","author":"Haynesworth","year":"1992","journal-title":"Bone."},{"key":"B16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science."},{"key":"B17","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp Hematol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Koc","year":"2000","journal-title":"J Clin Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp Hematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood."},{"key":"B21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","article-title":"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex","volume":"57","author":"Le Blanc","year":"2003","journal-title":"Scand J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e21703","DOI":"10.1371\/journal.pone.0021703","article-title":"Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses","volume":"6","author":"Moll","year":"2011","journal-title":"PLoS ONE."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1182\/blood-2012-03-420612","article-title":"Mesenchymal stem cells are injured by complement after their contact with serum","volume":"120","author":"Li","year":"2012","journal-title":"Blood."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/scrt94","article-title":"The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms","volume":"3","author":"Morando","year":"2012","journal-title":"Stem Cell Res Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.stem.2012.05.015","article-title":"Mesenchymal stromal cells: new directions","volume":"10","author":"Keating","year":"2012","journal-title":"Cell Stem Cell."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood."},{"key":"B27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bbmt.2005.01.005","article-title":"Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation","volume":"11","author":"Le Blanc","year":"2005","journal-title":"Biol Blood Marrow Transplant."},{"key":"B28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.smim.2018.01.002","article-title":"Mesenchymal-myeloid interaction in the regulation of immunity","volume":"35","author":"Cheung","year":"2018","journal-title":"Semin Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation."},{"key":"B30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2249.2011.04540.x","article-title":"Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro","volume":"167","author":"Karlsson","year":"2012","journal-title":"Clin Exp Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.4049\/jimmunol.179.5.2824","article-title":"The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells","volume":"179","author":"Jones","year":"2007","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1097\/TP.0b013e3181a2a4b3","article-title":"HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells","volume":"87","author":"Selmani","year":"2009","journal-title":"Transplantation."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1182\/blood-2010-02-270777","article-title":"Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells","volume":"116","author":"Gieseke","year":"2010","journal-title":"Blood."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1097\/TP.0b013e3181fed001","article-title":"Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression","volume":"90","author":"Ge","year":"2010","journal-title":"Transplantation."},{"key":"B37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/mt.2011.189","article-title":"Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation","volume":"20","author":"Francois","year":"2012","journal-title":"Mol Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/eji.200425405","article-title":"Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway","volume":"35","author":"Augello","year":"2005","journal-title":"Eur J Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.4049\/jimmunol.0902023","article-title":"Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression","volume":"184","author":"Ren","year":"2010","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.scr.2011.04.001","article-title":"Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes","volume":"7","author":"Saldanha-Araujo","year":"2011","journal-title":"Stem Cell Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","article-title":"Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis","volume":"10","author":"Akiyama","year":"2012","journal-title":"Cell Stem Cell."},{"key":"B42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/9783110298307.125","article-title":"Mesenchymal stem cells for graft-versus-host disease in experimental animal models","volume-title":"Stem Cell- Dependent Therapies-Mesenchymal Stem Cells in Chronic Inflammatory Disorders","author":"Sadeghi","year":"2013"},{"key":"B43","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1053\/j.gastro.2010.10.013","article-title":"Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes","volume":"140","author":"Parekkadan","year":"2011","journal-title":"Gastroenterology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"eaam7828","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci Transl Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Thery","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1399-3046.2007.00780.x","article-title":"Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs","volume":"11","author":"Fang","year":"2007","journal-title":"Pediatr Transplant."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.bbmt.2010.03.017","article-title":"Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population","volume":"16","author":"Lucchini","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"key":"B50","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bbmt.2010.04.014","article-title":"Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study","volume":"17","author":"Prasad","year":"2011","journal-title":"Biol Blood Marrow Transplant."},{"key":"B51","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1016\/j.bbmt.2009.12.057","article-title":"Prochymal improves response rates in patients with steroid-refractory acute graft versus host disease (SR-GVHD) involving the liver and gut: results of a randomized, placebo-controlled, multicenter phase III trial in GVHD","volume":"16","author":"Martin","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"key":"B52","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.bbmt.2019.08.029","article-title":"A phase 3 randomized study of remestemcel-L versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease","volume":"26","author":"Kebriaei","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"key":"B53","doi-asserted-by":"publisher","first-page":"S298","DOI":"10.1016\/j.bbmt.2009.12.426","article-title":"Treatment of steroid-refractory acute GVHD with mesenchymal stem cells improves outcomes in pediatric patients; results of the pediatric subset in a phase III randomized, placebo-controlled study","volume":"16","author":"Szabolcs","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"key":"B54","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/bjh.12545","article-title":"Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease","volume":"163","author":"Ball","year":"2013","journal-title":"Br J Haematol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.bbmt.2020.01.018","article-title":"A phase 3, single-arm, prospective study of remestemcel-l, ex vivo culture-expanded adult human mesenchymal stromal cells for the treatment of pediatric patients who failed to respond to steroid treatment for acute graft-versus-host disease","volume":"26","author":"Kurtzberg","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"key":"B56","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/bmt.2017.35","article-title":"Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III\/IV after hematopoietic stem cell transplantation","volume":"52","author":"Dotoli","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"B57","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/bmt.2016.317","article-title":"Good responses but high TRM in adult patients after MSC therapy for GvHD","volume":"52","author":"Salmenniemi","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121577","article-title":"Children and adults with refractory acute graft-versus-host disease respond to treatment with the mesenchymal stromal cell preparation \u201cMSC-FFM\u201d -outcome report of 92 patients","volume":"8","author":"Bonig","year":"2019","journal-title":"Cells."},{"key":"B59","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3324\/haematol.2015.140368","article-title":"Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey","volume":"101","author":"Ku\u00e7i","year":"2016","journal-title":"Haematologica."},{"key":"B60","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.bbmt.2011.07.023","article-title":"Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy","volume":"18","author":"von Bahr","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"key":"B61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1755-7682-4-27","article-title":"Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases","volume":"4","author":"Wernicke","year":"2011","journal-title":"Int Arch Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13287-020-01592-z","article-title":"Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis","volume":"11","author":"Morata-Tarifa","year":"2020","journal-title":"Stem Cell Res Ther."},{"key":"B63","first-page":"525","article-title":"Clinical spectrum of graft-versus-host disease","volume-title":"Graft vs Host Disease","author":"Ringd\u00e9n","year":"1996"},{"key":"B64","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","article-title":"Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression","volume":"57","author":"Sullivan","year":"1981","journal-title":"Blood."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1634\/stemcells.2007-0790","article-title":"Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells","volume":"26","author":"Parekkadan","year":"2008","journal-title":"Stem Cells."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/bmt.2010.195","article-title":"Mesenchymal stem cell as salvage treatment for refractory chronic GVHD","volume":"45","author":"Weng","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3324\/haematol.2010.038356","article-title":"Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I\/II clinical trial","volume":"96","author":"P\u00e9rez-Simon","year":"2011","journal-title":"Haematologica."},{"key":"B69","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/sctm.17-0167","article-title":"Placenta-derived decidua stromal cells for treatment of severe acute graft-versus-host disease","volume":"7","author":"Ringden","year":"2018","journal-title":"Stem Cells Transl Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/scd.2014.0265","article-title":"Treatment of severe chronic graft-versus-host disease with decidual stromal cells and tracing with (111)indium radiolabeling","volume":"24","author":"Erkers","year":"2015","journal-title":"Stem Cells Dev."},{"key":"B71","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant."},{"key":"B72","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1532\/IJH97.A30409","article-title":"Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation","volume":"80","author":"Chung","year":"2004","journal-title":"Int J Hematol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","article-title":"Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients","volume":"11","author":"Lazarus","year":"2005","journal-title":"Biol Blood Marrow Transplant."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","article-title":"Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells","volume":"21","author":"Le Blanc","year":"2007","journal-title":"Leukemia."},{"key":"B75","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.leu.2405090","article-title":"The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study","volume":"22","author":"Ning","year":"2008","journal-title":"Leukemia."},{"key":"B76","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbmt.2010.01.011","article-title":"Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning","volume":"16","author":"Baron","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"key":"B77","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/14653240902807018","article-title":"Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults","volume":"11","author":"Gonzalo-Daganzo","year":"2009","journal-title":"Cytotherapy."},{"key":"B78","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/bmt.2008.348","article-title":"Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial","volume":"43","author":"Macmillan","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1182\/blood-2007-04-087056","article-title":"Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation","volume":"110","author":"Ball","year":"2007","journal-title":"Blood."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1089\/scd.2009.0029","article-title":"Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study","volume":"18","author":"Meuleman","year":"2009","journal-title":"Stem Cells Dev."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1089\/scd.2009.1809.edi","article-title":"Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation","volume":"18","author":"Ringd\u00e9n","year":"2009","journal-title":"Stem Cells Dev."},{"key":"B82","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(81)91059-X","article-title":"Bone marrow transplantation for inborn errors","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet."},{"key":"B83","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00007890-198410000-00001","article-title":"Transplantation in relation to the treatment of inherited disease","volume":"38","author":"Groth","year":"1984","journal-title":"Transplantation."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S0301-472X(99)00101-0","article-title":"Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases","volume":"27","author":"Ko\u00e7","year":"1999","journal-title":"Exp Hematol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1097\/01.TP.0000159029.48678.93","article-title":"Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta","volume":"79","author":"Le Blanc","year":"2005","journal-title":"Transplantation."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1038\/sj.leu.2404833","article-title":"Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon","volume":"21","author":"Ringden","year":"2007","journal-title":"Leukemia."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1089\/scd.2015.0120","article-title":"Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua","volume":"24","author":"Moll","year":"2015","journal-title":"Stem Cells Dev."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/stem.1638","article-title":"Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses","volume":"32","author":"Yin","year":"2014","journal-title":"Stem Cells."},{"key":"B90","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.TP.0000133513.29923.44","article-title":"Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation","volume":"78","author":"Remberger","year":"2004","journal-title":"Transplantation."},{"key":"B91","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1600-065X.1985.tb01160.x","article-title":"Graft-versus-host disease in dog and man: the Seattle experience","volume":"88","author":"Storb","year":"1985","journal-title":"Immunol Rev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00007890-200102150-00017","article-title":"T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"71","author":"Mattsson","year":"2001","journal-title":"Transplantation."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1097\/00007890-199811270-00012","article-title":"Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients","volume":"66","author":"Ljungman","year":"1998","journal-title":"Transplantation."},{"key":"B94","first-page":"1059","article-title":"The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Sundin","year":"2006","journal-title":"Haematologica."},{"key":"B95","doi-asserted-by":"publisher","first-page":"899","DOI":"10.5966\/sctm.2013-0191","article-title":"Mesenchymal stromal cell therapy is associated with increased adenovirus-associated but not cytomegalovirus-associated mortality in children with severe acute graft-versus-host disease","volume":"3","author":"Calkoen","year":"2014","journal-title":"Stem Cells Transl Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/stem.1314","article-title":"Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease","volume":"31","author":"Ringden","year":"2013","journal-title":"Stem Cells."},{"key":"B97","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM198703193161207","article-title":"Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis","volume":"316","author":"Ringden","year":"1987","journal-title":"N Engl J Med"},{"key":"B98","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(05)61189-0","article-title":"Twelve-year-follow-up of the first allogeneic bone marrow transplantation for Langerhan's cell histiocytosis","volume":"349","author":"Ringd\u00e9n","year":"1997","journal-title":"Lancet"},{"key":"B99","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/leu.2017.265","article-title":"Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia","volume":"32","author":"Toft","year":"2018","journal-title":"Leukemia."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.bbmt.2019.05.034","article-title":"Long-term follow-up of a pilot study using placenta-derived decidua stromal cells for severe acute graft-versus-host disease","volume":"25","author":"Sadeghi","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B101","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/joim.12695","article-title":"What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?","volume":"283","author":"Ringd\u00e9n","year":"2018","journal-title":"J Intern Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1182\/blood.V75.3.555.bloodjournal753555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood."},{"key":"B103","first-page":"921","article-title":"Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. acute leukemia working party of the European group for blood and marrow transplantation","volume":"18","author":"Ringd\u00e9n","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"B104","first-page":"1062","article-title":"An analysis of factors predisposing to chronic graft-versus-host disease","volume":"13","author":"Ringd\u00e9n","year":"1985","journal-title":"Exp Hematol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-98-4-461","article-title":"Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings","volume":"98","author":"Storb","year":"1983","journal-title":"Ann Int Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S2352-3026(15)00224-0","article-title":"Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis","volume":"3","author":"Hashmi","year":"2016","journal-title":"Lancet Haematol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS ONE."},{"key":"B108","doi-asserted-by":"publisher","first-page":"100249","DOI":"10.1016\/j.eclinm.2019.100249","article-title":"Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis","volume":"19","author":"Thompson","year":"2020","journal-title":"EClinicalMedicine."},{"key":"B109","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3389\/fimmu.2019.00619","article-title":"Comparison of mesenchymal stromal cells from different origins for the treatment of graft-vs","volume":"10","author":"Gr\u00e9goire","year":"2019","journal-title":"Front Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1038\/leu.2015.212","article-title":"Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey","volume":"29","author":"Zeiser","year":"2015","journal-title":"Leukemia."},{"key":"B111","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbmt.2016.10.009","article-title":"Targeting integrin \u03b14\u03b27 in steroid-refractory intestinal graft-versus-host disease","volume":"23","author":"Fl\u00f8isand","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"B112","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.bbmt.2018.11.017","article-title":"Etanercept as treatment of steroid-refractory acute graft-versus-host disease in pediatric patients","volume":"25","author":"Faraci","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B113","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1200\/JCO.2004.06.102","article-title":"Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the acute leukemia working party of the european group for blood and marrow transplantation","volume":"22","author":"Ringden","year":"2004","journal-title":"J Clin Oncol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nm.1948","article-title":"Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation","volume":"15","author":"Morris","year":"2009","journal-title":"Nat Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.bbmt.2020.01.026","article-title":"Study 275: updated expanded access program for remestemcel-l in steroid-refractory acute graft-versus-host disease in children","volume":"26","author":"Kurtzberg","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"key":"B116","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/bmt.2010.275","article-title":"Mesenchymal stromal cells as treatment for chronic GVHD","volume":"46","author":"Ringden","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/bmt.2010.262","article-title":"Pooled MSCs for treatment of severe hemorrhage","volume":"46","author":"Ringd\u00e9n","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"B118","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.beha.2011.01.003","article-title":"Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages","volume":"24","author":"Ringden","year":"2011","journal-title":"Best Pract Res Clin Haematol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/ALN.0000000000000546","article-title":"Mesenchymal stem cell therapy for acute respiratory distress syndrome: a light at the end of the tunnel?","volume":"122","author":"Lee","year":"2015","journal-title":"Anesthesiology."},{"key":"B120","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1164\/rccm.201701-0107CP","article-title":"Fifty Years of Research in ARDS. Cell-based therapy for acute respiratory distress syndrome. biology and potential therapeutic value","volume":"196","author":"Laffey","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.21037\/jeccm.2018.02.04","article-title":"Paediatric acute respiratory distress syndrome: progress over the past decade","volume":"2","author":"Wang","year":"2018","journal-title":"J Emerg Crit Care Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-2600(15)00047-8","article-title":"Mesenchymal stem (stromal) cells for treatment of acute respiratory distress syndrome","volume":"3","author":"Ringd\u00e9n","year":"2015","journal-title":"Lancet Respir Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2157-7633.1000244","article-title":"Successful reversal of acute lung injury using placenta-derived decidual stromal cells","volume":"4","author":"Ringden","year":"2014","journal-title":"J Stem Cell Res Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e33115","DOI":"10.1371\/journal.pone.0033115","article-title":"Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury","volume":"7","author":"Bruno","year":"2012","journal-title":"PLoS ONE."},{"key":"B126","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","article-title":"Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury","volume":"4","author":"Lai","year":"2010","journal-title":"Stem Cell Res."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1161\/CIRCULATIONAHA.112.114173","article-title":"Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension","volume":"126","author":"Lee","year":"2012","journal-title":"Circulation."},{"key":"B128","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nbt0712-571a","article-title":"NCATS launches drug repurposing program","volume":"30","author":"Allison","year":"2012","journal-title":"Nat Biotechnol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12185-019-02804-w","article-title":"Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells","volume":"111","author":"Sadeghi","year":"2020","journal-title":"Int J Hematol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.567210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T02:32:54Z","timestamp":1617935574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.567210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":129,"alternative-id":["10.3389\/fimmu.2020.567210"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.567210","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"article-number":"567210"}}